The Genome Revolution

Richter, S. (2018). The Genome Revolution. "Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'".

Type

Report

Intellectual base

Grey literature

Year

2018

Link

https://www.cnbc.com/2018/04/11/goldman-asks-is-curing-patients-a-sustainable-business-model.html

Cited from

organizational_management

Cited by

1 citation across 1 artifact.

Each citation links to the sentence it supports in the citing article.

Primes

• Shirky Principle
  • In medicine and chronic-care infrastructure, clinics, device makers, and pharmaceutical franchises depend on ongoing management rather than cure.

    This sourceDocuments the explicit financial logic that one-shot cures threaten recurring revenue versus chronic therapies — the medicine/chronic-care incentive favoring ongoing management over cure.

Verification

This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.

Registry ID ref:e0d619be6b6a · see in the full table